Author:
Roma Cristin,Esposito Abate Riziero,Sacco Alessandra,Califano Daniela,Arenare Laura,Bergantino Francesca,Pisano Carmela,Cecere Sabrina Chiara,Scambia Giovanni,Lorusso Domenica,Artioli Grazia,Tasca Giulia,Spina Anna,Russo Daniela,Gadducci Angiolo,De Angelis Carmine,Bologna Alessandra,Marchini Sergio,Capoluongo Ettore Domenico,Perrone Francesco,Pignata Sandro,Normanno Nicola
Funder
Associazione Italiana per la Ricerca sul Cancro
Reference29 articles.
1. Global Burden of Disease. 2019.
2. Associazione Italiana di Oncologia Medica. I numeri del cancro 2022.
3. High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints;Lisio;Int J Mol Sci,2019
4. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial;Banerjee;Lancet Oncol,2021
5. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial;Coleman;Lancet,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献